Versaci F, Gaspardone A, Tomai F, Proietti I, Ghini A S, Altamura L, Andò G, Crea F, Gioffrè P A, Chiariello L
Division of Cardiac Surgery, Università Tor Vergata, Rome, Italy.
Heart. 2004 Jun;90(6):672-5. doi: 10.1136/hrt.2003.020826.
Stent implantation for isolated stenosis of the proximal left anterior descending coronary artery (LAD) with preserved left ventricular function has been found to have a better clinical and angiographic outcome at one year than balloon angioplasty (PTCA).
To establish whether those results are maintained at five year follow up.
Patients were followed at least every six months. For those who died during follow up, data were obtained from medical records.
Freedom from death, non-fatal myocardial infarction, cerebrovascular accident, and repeated target lesion revascularisation. Secondary end points were revascularisation in a remote region and freedom from angina.
Follow up was complete in all patients. At five years, the primary end point was reached more often by patients randomised to stent implantation than to PTCA (80% v 53%; odds ratio (OR) 0.29 (95% confidence interval (CI) 0.13 to 0.69); p = 0.0034). In the PTCA group, 35% of patients underwent target lesion revascularisation v 15% in the stent group (OR 0.33, 95% CI 0.13 to 0.80; p = 0.014). There was a trend towards increased mortality in the PTCA group than in the stent group (17% v 7%; OR 0.36, 95% CI 0.10 to 1.21; p = 0.098). No significant differences were found between PTCA and stent groups for non-fatal myocardial infarction (8% v 5%; OR 0.58, 95% CI 0.13 to 2.54; p = 0.46) or cerebrovascular accident (2% v 0%).
In patients with isolated stenosis of the proximal LAD, a five year clinical follow up confirmed a better outcome in those treated with stenting than with PTCA.
对于左前降支近端孤立性狭窄且左心室功能保留的患者,冠状动脉支架植入术在术后一年的临床和血管造影结果优于球囊血管成形术(PTCA)。
确定这些结果在五年随访期内是否依然保持。
患者至少每六个月接受一次随访。对于随访期间死亡的患者,数据从医疗记录中获取。
无死亡、非致死性心肌梗死、脑血管意外以及靶病变再次血管重建。次要终点为远处血管重建和无心绞痛。
所有患者均完成随访。五年时,随机接受支架植入术的患者达到主要终点的比例高于接受PTCA的患者(80% 对 53%;优势比(OR)0.29(95%置信区间(CI)0.13至0.69);p = 0.0034)。在PTCA组中,35%的患者接受了靶病变血管重建,而支架组为15%(OR 0.33,95% CI 0.13至0.80;p = 0.014)。PTCA组的死亡率有高于支架组的趋势(17% 对 7%;OR 0.36,95% CI 0.10至1.21;p = 0.098)。PTCA组和支架组在非致死性心肌梗死(8% 对 5%;OR 0.58,95% CI 0.13至2.54;p = 0.46)或脑血管意外(2% 对 0%)方面未发现显著差异。
对于左前降支近端孤立性狭窄的患者,五年临床随访证实,支架植入术治疗的患者比PTCA治疗的患者预后更好。